Transcript Jacques Gagnon - the Fisheries Council of Canada
OVERVIEW R&D, Laboratories and Analysis Services
Gastien Godin General Manager Jacques Gagnon, PhD Scientific Director Fishery and Marine Coproducts Division Fredericton , NB October 8th, 2014
COASTAL ZONES RESEARCH INSTITUTE (CZRI)
• • • • LAND & PEATLANDS MANAGEMENT- AGRICULTURE & RENEWABLE RESOURCES- ADAPTATION TO CLIMATIC CHANGE AQUACULTURE FISHERY AND MARINE COPRODUCTS LABORATORIES AND ANALYSIS SERVICES • • CZRI Highlights – Value Added Food Sector Mobile Pilot Unit
2
LAND & PEATLANDS MANAGEMENT- AGRICULTURE & RENEWABLE RESOURCES ADAPTATION TO CLIMATIC CHANGE
Dr. Mathieu Quenum – Scientific Director
Email : [email protected] Tel. : (506) 336-6600
Fields of Expertise and Strategic Research Concentration Biomass & Bioenergy Horticulture, Agriculture & Berries Sustainable Production of Sphagnum & Added Value Products Soil, Water & Environment Sustainable Development in Coastal Areas 3
AQUACULTURE
Dr. André Dumas– Scientific Director
Email : andré[email protected] Tel. : (506) 336-6600
Fields of Expertise Nutrition of fish and crustaceans Nutrition modelling Arctic charr, salmon, oyster and lobster production Product development and innovation management
Research focus areas Nutritional evaluation of commodity and innovative ingredients, prebiotics, probiotics, immunostimulants Nutrigenomics 4
FISHERY AND MARINE COPRODUCTS
Dr. Jacques Gagnon– Scientific Director
Email : [email protected] Tel. : (506) 336-6600
Fields of Expertise
Development of green processes Lab scale spaces with hydrolysis, drying & centrifugation capacities 53’ pilot multifunctional unit for turnkey project on site Product development and innovation management Research focus areas
Valorization and commercialisation of marine coproducts Natural health products 5
LABORATORIES AND ANALYSIS SERVICES
Chemical/microbiological analyses
Environmental, nutritional, etc.
Food safety
ISO/IEC 17025 (CALA) R&D support
Fatty acids & pigments Amino acids (in development)
Personnalized services
On-site, technical, process design, etc.
Regulatory support, nutritional labelling, shelf life
Coproducts recovery and characterization
6
Mobile Pilot Unit
• • • • • • Various tanks (2 x 1500 liters) 8 x 100 liters double walls for temperature control Various pumps Filtration unit (sweco) Mixers Etc.
• • • • 53 feet reefer trailer Processing room with temp. control Walk-in cold room and freezer 600, 220, 110 volts connections
OPEN FOR BUSINESS We look forward to new collaboration opportunities!
7
Highlights – Value-Added Food Sector
• CZRI co-hosted (with AFBPA) the Sixth Acadian Peninsula Food Processing Conference
“Growing Our Industry: Making history with the new biotechnologies”
www.shippagan.ca
Acadian Peninsula Convention Centre, Shippagan, NB May 21-23, 2014
8
MAXIMIZING THE VALUE OF MARINE COPRODUCTS: APPLICATIONS IN NUTRISCIENCES Jacques Gagnon, PhD and colls.
Fisheries Council of Canada 2014 Conference October 8th
Valorization of effluents, residues and marine coproducts
VALEUR.COM
VALEUR.COM = VAL
orisation des
E
ffluents d'
U
sine, des
R
ésidus et des
CO
produits
M
arins) Full title –AIF project:
DEVELOPMENT AND COMMERCIALIZATION OF MARINE COPRODUCTS FOR USE IN ANIMAL AND HUMAN NUTRITION AND ITS APPLICATION TO THE PREVENTION OF OBESITY, DIABETES AND NEURODEGENERESCENCE
CZRI research team: Nadia Tchoukanova Sébastien Plante and Jacques Gagnon
BioAtlantech Survey (Biosciences)
Geographical clustering aquaculture and marine St. George/St. Andrews (7 Companies + 2 Research Institutions) Acadian Peninsula (7 Companies + 1 Research Institution) Now BioNB, 2013
LIST OF COPRODUCTS
SEA, PROCESSING AND AQUAFEED: A VALUE CREATION PATHWAY OF SEAFOOD RAW MATERIALS
André Dumas, PhD & colls
The Fisheries Council of Canada 2014 conference
Aquaculture in the World
100 80 60 40 20 0
2000 2010 2020 Source: FAO (2012)
Aquafeeds in the World
• • •
20 to 23 millions MT aquafeed/yr (2006) ~3.7 million MT/yr fish meal (FM) = $5.5 bln ~0,8 million MT/yr of fish oil (FO) = $1.0 bln
Source: Tacon & Metian (2008)
FM: source of beneficial nutrients
• • • •
Essential amino acids (AA) Valuable AA: Taurine, hydroxyproline Vitamins (e.g. B12) Minerals (e.g. available P)
FO: source of beneficial fatty acids
•
Omega-3 to meet consumer expectations
FM & FO cost
Source: Tacon & Metian (2008)
Alternatives to FM & FO: what does the sea have to offer?
•
Seafood processing by-products from sustainably managed fisheries
•
New business opportunities
Shrimp processing
Recycled 30% Residues (70%) Liquid Solids
Photos: http://dailyfoodporn.wordpress.com/tag/nordic-shrimp/
Shrimp residue meal
Shrimp residue meal
70 60 50 40 30 20 10 0 Protein Lipid Ash Fiber Proximate composition P
3,0 2,0 1,0 0,0 7,0 6,0 5,0 4,0
Shrimp residue meal
Shrimp residue Herring Arg Cys His Iso Leu Lys Met Phe Thr Try Val EAA
Shrimp residue meal (SRM
)
6
Commercial SRM
4 2 0
Initial Final
CONCLUSION
1. SRM:
•Candidate alternative to $$$ sources of beneficial nutrients
2. Next steps
•Approval by regulatory agencies
LABORATORIES AND ANALYSIS SERVICES: BIOCHEMICAL CHARACTERIZATION OF MARINE PRODUCTS AND COPRODUCTS Josée Boudreau, PhD, Marie-Hélène Thibault, PhD, Claude Pelletier, M.Sc, Mathieu Ferron, M.SC
25
MARINE PROCESSING COPRODUCTS
Over the years, our multidisciplinary team has developped an expertise in the screening and characterization of several marine processing coproducts such as:
Sea cucumber
• Mouth • Anus • Viscera
Arctic shrimp
• Cephalothorax • Shell • Protein waste
Lobster
• Head • Head • Tail • Viscera
Snow crab
• Hepatopancreas • Shell
Herring
• Milt • Roe 26
CHARACTERIZATION OF MARINE COPRODUCTS
In a first step,
proximate analysis
, using standard methods, reveals the major constituents in the products under study
Immature herring roe Herring milt Humidity 70% Crude protein 24% Crude fat 5% Ash 1% Humidity 77% Crude protein 18% Crude fat 3% Ash 2%
27
CHARACTERIZATION OF MARINE COPRODUCTS
Each class of compounds can be probed further to gain knowledge about the product at hand and the biomolecules it contains
Immature herring roe Humidity 70% Crude protein 24%
• Marine products are known to be rich in
phospholipids
and
omega-3 fatty acids
, as well as
Crude fat 5% Ash 1%
fat-soluble biomolecules such as
vitamins
(A, D, E) and marine coproducts
pigments
• Lipids are therefore often one of the main focuses in the study of 28
MARINE COPRODUCT LIPIDS
Each
Lipid classes
• Phospholipids • Sterols • Triglycerides • Wax esters • Neutral
vs
polar lipids
Rancidity/oxidation
• Free fatty acids (FFA) • Peroxide value • p-anisidine value
Fatty acid profile
• Omega 3 • Omega 6 • EPA, DHA • Saturated • Mono-, poly unsaturated
Other bioactive molecules
• Vitamins (A, D and E) • Carotenoid pigments (Astaxanthin , β-carotene, etc.) 29
MARINE COPRODUCT PIGMENTS
Current projects in our laboratories include the detailed study and characterization of
astaxanthin
, a widespread and commercially relevant marine pigment, in shellfish processing coproducts.
Astaxanthin For animals:
• Widely used in aquaculture for flesh pigmentation improved fish growth
For humans:
• Powerful antioxidant • Anti-tumor • Anti-inflammatory • Protects against cardiovascular diseases and ulcers • Treats neurodegenerative diseases 30
ASTAXANTHIN ANALYSIS Various chemical forms
of astaxanthin naturally occur and influence its biological properties and stability. Different analytical methods are required to study these complex molecules.
Astaxanthin 1. Free or with fatty acid(s)
Free, monoester or diester
2. Geometrical isomers
All trans, 9-cis, 13-cis, etc.
3. Optical isomers
{R,R ’}, {R,S’} (MESO), {S,S’ }
31
ASTAXANTHIN ANALYSIS
Current analytical capabilities in our laboratories include: Quantification of
free
,
esterified
and
total
astaxanthin Identification of geometrical isomers (
all trans
, 9-
cis
, 13-
cis
, etc.)
High performance liquid chromatography (HPLC)
Normal phase Reversed phase Chiral reversed phase
RAMAN and FT-Infrared microspectroscopy
Microscope for
in situ
«
Same spot
imaging » technology for heterogeneous sample mapping Work is in progress to develop a rapid, simple,
in situ
method for the identification of astaxanthin optical isomers in different products 32
Fishery coproduct as nutraceutics (natural health products and functional foods): Innovation based technology
Neurodegeneration 1. Anti-diabetes 2. Anti-inflammatory 3. Anti-obesity 4. Neuroprotection Diabetes Insulin resistance Obesity Inflammation
Valorization of Coproducts from fish processing plants
CZRI Purification Analyses Process development Pilot scale unit NRC- Halifax Bioguided fractionation Purification Adipocytes cell model (Obesity) NRC- Charlottetown
in vitro
and
in vivo
diabetes model Bioguided fractionation Dalhousie University
in vitro
and
in vivo
Alzheimer model Jacques Gagnon
CZRI phases
Aquaculture or marine biomass • Animal feed • Natural health products (NHPs) • Human food products New, added-value products CZRI • Product formulation • Product stability • Market opportunities Product development Lead bioactives Chemical analysis • Fish cuttings • Shrimp • Sea cucumbers Bio-analysis • Natural product chemistry extraction • Chemical fractionation • Chemical characterization • •
In vitro
bioassays
In vivo
models • Scale up • Food technology centers • Partnering initiatives
Dr. Bob Chapman
Summary
• Extracts and protein hydrolysates prepared: ~100 • Focus on lead products that would be beneficial in metabolics disorders (e.g. pre-diabetes, obesity), be neuroprotective, or anti-inflammatory •Shrimp extracts and herring milt hydrolysates gave good activity for antidiabetic and neuroprotective effects •These should be further assessed by the development of health supplement ingredients with animal model of alzheimer’s disease and diabetes Jacques Gagnon
Funding Agencies
• Atlantic Canada Opportunities Agencies (ACOA)- Atlantic Innovation Fund (AIF) •New Brunswick Innovation Fund (NBIF) •Industrial Partners: ex: Island Fishermen Cooperative Association •New Brunswick Department of Agriculture, Aquaculture and Fisheries Jacques Gagnon
Patent No.
Kind WO 2014138920 A1 Date Sep 18, 2014 Application No.
WO 2014-CA251 Date Mar 13, 2014
What is in the pipeline
Patent published … more to come with antidiabetic activities of shrimp oil Market feasability study with shrimp oil in progress Animal model of diabetes and neurodegeneration with shrimp oil and herring milt hydrolysate to confirm positive effects are in progress Looking for a commercial receptor partner Data collection in animal models to support a human clinical trial with shrimp oil (NHP) Purification process of shrimp oil for human use at lab scale- with scaling up at industrial level Jacques Gagnon
THANK YOU